Clinical Trials Logo

Kidney Transplantation clinical trials

View clinical trials related to Kidney Transplantation.

Filter by:

NCT ID: NCT05635136 Completed - Clinical trials for Kidney Transplantation

Histopathological Analysis of Renal Biopsies With Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings in Kidney Transplant Recipients (HARBOR)

HARBOR
Start date: February 1, 2022
Phase:
Study type: Observational [Patient Registry]

Banff classification stands as gold standard and international consensus for the identification, diagnosis and categorization of renal allograft pathology. In addition to multiple revision dedicated to the clarification and refinement of these diagnostic categories, a special attention is now dedicated to the development of automated protocols serving the use of artificial intelligence in digital pathology. To be integrated in the actual early post-transplant monitoring procedure, such original approach is considered to match various growing expectations of clinicians and pathologists regarding the future of transplant nephropathology : decrease inter-observer variability, reduce human errors and limit time-consuming analysis of kidney biopsy. Among these, an accelerated reading and access to Banff diagnostic criteria could help initiating both appropriate and immediate treatment to improve graft survival in kidney transplant recipients. Yet conventional histopathology still requires the preparation of a paraffin block, sections as well as subsequent colorations that altogether delay the final pathological diagnosis and urge the need for additional diagnostic modalities. Designed to overcome this critical limitation, the HARBOR study intends to test the performance of direct histopathological examination of fresh kidney biopsy with full-field optical coherence tomography for the identification of Banff elemental lesions and diagnostic categories.

NCT ID: NCT05619679 Completed - Clinical trials for Kidney Transplant Failure

A Clinical Practice Snapshot on Pediatric Kidney Transplantation

Start date: January 10, 2022
Phase:
Study type: Observational

The aim is to create an overview of the similarities and differences in daily practice among the different centers performing pediatric kidney transplantation in Europe. For this purpose, a Clinical Practice Snapshot will be used to provide insight in the current approaches.

NCT ID: NCT05572775 Completed - Laparoscopy Clinical Trials

Post-surgical Chronic Pain After Retroperitoneal Laparoscopic Living Kidney Donor

Start date: January 1, 2023
Phase:
Study type: Observational

This study aimed to determine the relationship between the quadratus lumborum and erector spinae plane block technique and the incidence and severity of chronic post-surgical pain in accordance with Brief Pain Inventory Score (BPI) in retroperitoneal laparoscopic living kidney donor surgery

NCT ID: NCT05280197 Completed - Clinical trials for Kidney Transplantation

Does an Abdominal Wall Nerve Block During Surgery Help Reduce Pain From Kidney Transplantation?

Start date: January 8, 2022
Phase: N/A
Study type: Interventional

This is a randomized, placebo controlled, double blind study to determine the effectiveness of a Transversus Abdominis Plane (TAP) block for reducing postoperative pain and opioid use in kidney transplant recipients.

NCT ID: NCT05240274 Completed - Clinical trials for End Stage Renal Disease

The POWERED Study: Prophylaxis With Metformin to Prevent PTDM

POWERED
Start date: January 25, 2019
Phase: Phase 2
Study type: Interventional

PrOphylaxis With mEtformin to pREvent PTDM: a single site, placebo controlled, double blind randomised clinical trial evaluating the effectiveness of metformin to prevent post-transplant diabetes in a cohort of patients undergoing renal transplantation.

NCT ID: NCT05229939 Completed - Clinical trials for Kidney Transplantation

Estimating Glomerular Filtration Rate in Kidney Transplant Recipients

Start date: January 1, 2000
Phase:
Study type: Observational

Accurate estimation of the glomerular filtration rate (GFR) is crucial for the management of kidney recipients, since it is the most predictive parameter of allograft failure that drives patient monitoring and decision-making. Standard and recent race-free GFR equations have been developed in native kidneys, but their performances in transplant kidney population remains unknown. We aimed at developing a kidney-transplant-specific GFR equation, and comparing its performance to standard GFR equations.

NCT ID: NCT05200949 Completed - Clinical trials for Kidney Transplant Failure

SURGICAL EXPERIENCE ON RENAL TRANSPLANT COMPLICATIONS

IMPACT
Start date: January 1, 2013
Phase:
Study type: Observational

Kidney transplantation (KT) failure could be due to surgery dependent factors and particularly surgeon's experience. Objective: To assess the impact of the surgeon's experience on the post-operative outcomes to know if it safe for young surgeons to perform it.

NCT ID: NCT05153915 Completed - Clinical trials for Kidney Transplantation

A Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

Start date: December 30, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study is to observe the safety and efficacy of Modigraf in de novo pediatric allograft liver and kidney transplantation recipients. This study will also monitor dose changes and tacrolimus whole blood trough levels of Modigraf based immunosuppression regimen.

NCT ID: NCT05152628 Completed - Clinical trials for Kidney Transplantation

A Study of Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

Start date: January 11, 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the pharmacokinetics of tacrolimus following oral administration of Modigraf, after the first oral dose and at steady state in pediatric participants undergoing de novo allograft liver or kidney transplantation. This study will also observe the safety and efficacy of Modigraf in de novo pediatric allograft liver and kidney transplantation recipients.

NCT ID: NCT05142748 Completed - Clinical trials for Kidney Transplant Infection

Study of Pulmonary Infections (Pneumonia) in Kidney Transplant Recipients Admitted to Hospital

Start date: September 1, 2019
Phase:
Study type: Observational

The investigators aimed to identify prognosis factors associated with in-hospital complications and assess the epidemiology, management, and outcomes of community-acquired pneumonia in a kidney transplant recipients' cohort. The investigators intend to identify each stay by a national database. Then they will be consulted by 2 clinicians to assert CAP clinical definition. After that radiographic evidence will be reviewed to validate CAP diagnoses. Then clinical data are collected in each center.